Literature DB >> 29531175

Intensive Blood Pressure Targets for Diabetic and Other High-Risk Populations: A Pooled Individual Patient Data Analysis.

Rahul Aggarwal1, Jackson Steinkamp2, Nicholas Chiu2, Benjamin Petrie2, Haares Mirzan2.   

Abstract

Optimal blood pressure (BP) targets for different populations, especially diabetics, remain uncertain after conflicting data on intensive management. We assessed whether a <120 mm Hg systolic target is beneficial and whether certain patient populations differ in response. Individual patient data of 14 094 patients from 2 randomized control trials was pooled. Seven thousand forty patients were assigned to an intensive target of <120 mm Hg and 7054 patients to a standard target of <140 mm Hg in an intention-to-treat analysis. The primary outcome was a composite of myocardial infarction, other acute coronary syndromes, stroke, heart failure, and cardiovascular mortality. Interactions between treatment and baseline characteristics were assessed. Secondary outcomes included nonfatal myocardial infarction, stroke, heart failure, cardiovascular mortality, and overall mortality. Intensive management significantly lowered primary outcome rate (hazard ratio, 0.83; 95% confidence interval, 0.74-0.92; P<0.001). No significant interaction was observed between treatment effect and diabetes mellitus status (P=0.16). Significantly reduced secondary outcomes included stroke (hazard ratio, 0.75; P=0.033) and heart failure (hazard ratio, 0.76; P=0.014). No significant interactions were observed between treatment effect and baseline age, sex, race, cardiovascular disease history, systolic BP, or diastolic BP (P values: 0.40, 0.95, 0.54, 0.18, 0.86, and 0.67, respectively). BP targets of <120 mm Hg improved cardiovascular outcomes. Diabetic patients responded similarly to this intervention, as did those with different age, sex, cardiovascular disease history, baseline BPs, and race. The intensive group had increased risk of intervention-related adverse outcomes (3.97% versus 1.53%; P<0.001). Clinicians should consider <120 mm Hg systolic targets for a variety of patients, including diabetics.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  acute coronary syndrome; blood pressure; diabetes mellitus; hypertension; myocardial infarction

Mesh:

Year:  2018        PMID: 29531175     DOI: 10.1161/HYPERTENSIONAHA.117.10713

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  1 in total

1.  Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry.

Authors:  Emmanuelle Vidal-Petiot; Emmanuel Sorbets; Deepak L Bhatt; Gregory Ducrocq; Yedid Elbez; Roberto Ferrari; Ian Ford; Jean-Claude Tardif; Michal Tendera; Kim M Fox; Philippe Gabriel Steg
Journal:  Eur Heart J       Date:  2018-11-14       Impact factor: 29.983

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.